Macrophage phenotype in mice deficient in both macrophage-colony-stimulating factor (op) and apolipoprotein E

Arteriosclerosis, Thrombosis, and Vascular Biology
W J de VilliersS Gordon

Abstract

Mice deficient in both macrophage-colony-stimulating factor (M-CSF, op) and apolipoprotein E (apoE) have elevated cholesterol levels but are protected from atherosclerosis. To assess the contribution of macrophage (Mphi) phenotypic heterogeneity and scavenger receptor (SR-A) expression to this seeming paradox, we characterized the Mphi phenotype by immunohistochemistry in these animals. Lesion size was determined in animals fed a chow or Western-type diet, and lipoprotein clearance studies were performed in vivo. Op0/E0 mice have fourfold smaller aortic root lesions than op2/E0 animals despite 2.5-fold higher total plasma cholesterol levels. Mphis in atherosclerotic lesions of op2/E0 mice constitute a predominantly recruited and M-CSF-dependent population. In addition, Mphis in different locations in plaques show phenotypic heterogeneity. SR-A expression in op0/E0 mice is reduced in proportion to the decrease in Mphi numbers, and M-CSF is thus not an essential requirement for SR-A expression in vivo. M-CSF-deficient mice degrade injected AcLDL , showing an adequate level of SR-A activity present in vivo. In contrast, beta-VLDL clearance in op0/E0 mice is decreased, implicating monocytes/Mphis in its catabolism. There is promine...Continue Reading

References

Jan 1, 1979·Immunological Reviews·J A Ledbetter, L A Herzenberg
Sep 1, 1992·The Journal of Experimental Medicine·T K van den BergG Kraal
Sep 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·A M HenneyS Humphries
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·W Wiktor-JedrzejczakE R Stanley
Apr 1, 1981·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S M HsuH Fanger
Oct 1, 1981·European Journal of Immunology·J M Austyn, S Gordon
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·J D SmithM Miyata
Aug 1, 1994·The Journal of Experimental Medicine·W J de VilliersS Gordon
Jan 1, 1995·Annual Review of Nutrition·A S Plump, J L Breslow
Oct 18, 1996·The Journal of Biological Chemistry·S A SchreyerR C LeBoeuf
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·M P RamprasadD Steinberg

❮ Previous
Next ❯

Citations

Apr 5, 2001·Current Atherosclerosis Reports·F Mach
May 21, 2005·Atherosclerosis·Jane E MurphySreenivasan Ponnambalam
Jul 28, 2013·Immunobiology·Ioana Madalina Fenyo, Anca Violeta Gafencu
Oct 8, 1999·Clinica Chimica Acta; International Journal of Clinical Chemistry·J DavignonL Bernier
Jan 14, 1999·The New England Journal of Medicine·R Ross
May 20, 2008·Cardiovascular Research·Robert KleemannTeake Kooistra
Sep 12, 2012·Current Opinion in Lipidology·Karina Di Gregoli, Jason L Johnson
Jan 11, 2013·TheScientificWorldJournal·Elisabetta ProfumoRachele Riganò
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Melissa HunterClay Marsh
Apr 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Miranda van EckGerd Schmitz
May 14, 2016·Thrombosis and Haemostasis·Eliana MontanariJohann Wojta
Feb 4, 2003·Journal of Lipid Research·Maria C de BeerWillem J S de Villiers
Nov 21, 2007·FEBS Letters·Attila Szanto, Tamás Roszer
Jul 19, 2006·Canadian Journal of Physiology and Pharmacology·Stewart C Whitman, Tanya A Ramsamy
May 17, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·John E Mindur, Filip K Swirski
Aug 1, 2013·Physiological Reviews·Paul N Hopkins
Apr 17, 2015·World Journal of Clinical Cases·Fulya Ilhan, Sevgi Tas Kalkanli
Mar 26, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christian A GleissnerKlaus Ley
May 15, 2015·Journal of Cellular and Molecular Medicine·Dimitry A ChistiakovAlexander N Orekhov
Nov 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zoran V PopovicHermann-Josef Gröne
Jan 3, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Grith L SorensenUffe Holmskov
Jan 25, 2002·Annals of the New York Academy of Sciences·J D SmithJ L Breslow
Oct 29, 2010·International Journal of Hypertension·Sam L StephenSreenivasan Ponnambalam
Oct 23, 2020·Arteriosclerosis, Thrombosis, and Vascular Biology·Satyesh K SinhaAldons J Lusis
May 25, 2002·Progress in Cardiovascular Diseases·Neuza LopesPascal J Goldschmidt
Apr 28, 2004·Biochemical and Biophysical Research Communications·Gemma LlaveriasMarta Alegret
Dec 13, 2005·Current Opinion in Immunology·Violeta Chitu, E Richard Stanley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

Clinica Chimica Acta; International Journal of Clinical Chemistry
A TakizawaA Tanaka
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
C DongP J Goldschmidt-Clermont
© 2022 Meta ULC. All rights reserved